The Support for Cancer Clinical Trials Program provides funding to Australia's Multi-site Collaborative Cancer Clinical Trials Groups to build their capacity to undertake cancer clinical trials.

The 2024-2027 Support for Cancer Clinical Trials (SCCT) grant round is open for invited applicants and closes 27 May 2024 1700 AEST.

The 2024-2027 SCCT Grant Opportunity Guidelines, application form and grant agreement template may be accessed at GrantConnect.

Clinical trials are fundamental to establishing whether new cancer treatments or new ways of using existing therapies, diagnostic tests, preventative or supportive interventions are effective and they help generate the evidence for best-practice cancer care.

Cancer Australia supports cancer clinical trials in Australia in the following ways:

Cancer Australia is also undertaking specific work on increasing clinical trial information available to consumers.